Department of Reproductive Endocrinology and Infertility, Mayo Clinic, Rochester, Minnesota; Atrium Health, Charlotte, North Carolina.
Biostatistics, Boston University SPH, Boston, Massachusetts.
Fertil Steril. 2020 Mar;113(3):569-577.e1. doi: 10.1016/j.fertnstert.2019.10.007. Epub 2020 Feb 7.
OBJECTIVE: To compare incidence, risk factors, and etiology of women's deaths in fertile, subfertile, and undergoing assisted reproductive technology (ART) in the years after delivery. DESIGN: Retrospective cohort. SETTING: University hospital. PATIENT(S): Women who had delivered in Massachusetts. INTERVENTION(S): This study used data from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System linked to vital records, hospital stays, and the Massachusetts death file. Mortality of patients delivered from 2004-2013 was evaluated through 2015. The exposure groups, determined on the basis of the last delivery, were ART-treated (linked to Society for Assisted Reproductive Technology Clinic Outcome Reporting System), subfertile (no ART but with indicators of subfertility including birth certificate checkbox for fertility treatment, prior hospitalization for infertility [International Classification of Disease codes 9 628 or V23], and/or prior delivery with checkbox or ART), or fertile (neither ART nor subfertile). Numbers (per 100,000 women-years) and causes of death were obtained from the Massachusetts death file. MAIN OUTCOME MEASURE(S): Mortality of women after delivery in each of the three fertility groups and the most common etiology of death in each. RESULT(S): We included 483,547 women: 16,429 ART, 11,696 subfertile, and 455,422 fertile among whom there were 1,280 deaths with 21.1, 25.5, and 44.7 deaths, respectively, per 100,000 women-years. External causes (violence, accidents, and poisonings) were the most common reasons for death in the fertile group. Deaths occurred on average 46 months after delivery. When external causes of death were removed, there were 19.1, 17.0, and 25.6 deaths per 100,000 women-years and leading causes of death in all groups were cancer and circulatory problems. CONCLUSION(S): The study presents reassuring data that death rates within 5 years of delivery in ART-treated and subfertile women do not differ from those in fertile women.
目的:比较生育、不孕和接受辅助生殖技术(ART)后女性在产后年份的发病率、危险因素和病因。
设计:回顾性队列研究。
地点:大学医院。
患者:在马萨诸塞州分娩的妇女。
干预措施:本研究使用了来自辅助生殖技术协会临床结果报告系统的数据,并与生命记录、住院情况和马萨诸塞州死亡档案相关联。通过 2015 年评估了 2004-2013 年期间分娩的患者的死亡率。根据最后一次分娩确定的暴露组包括接受 ART 治疗的患者(与辅助生殖技术协会临床结果报告系统相关联)、不孕患者(未接受 ART,但有生育治疗的指标,包括出生证明生育治疗复选框、不孕住院[国际疾病分类代码 9628 或 V23]和/或以前的分娩伴有复选框或 ART)和生育能力正常的患者(既未接受 ART 治疗也未不孕)。从马萨诸塞州死亡档案中获得了每 10 万名妇女年的死亡人数和死因。
主要观察指标:三种生育组产后妇女的死亡率以及每种组别的最常见死因。
结果:我们纳入了 483547 名妇女:16429 名接受 ART 治疗、11696 名不孕和 455422 名生育能力正常,其中分别有 21.1、25.5 和 44.7 人/10 万妇女年死亡。外部原因(暴力、事故和中毒)是生育能力正常组死亡的最常见原因。死亡平均发生在分娩后 46 个月。当去除外部原因导致的死亡后,ART 治疗组、不孕组和生育能力正常组的死亡人数分别为 19.1、17.0 和 25.6 人/10 万妇女年,所有组别的主要死因都是癌症和循环系统问题。
结论:本研究提供了令人安心的数据,表明接受 ART 治疗和不孕的女性在产后 5 年内的死亡率与生育能力正常的女性没有差异。
J Assist Reprod Genet. 2019-8-14
Fertil Steril. 2018-8
Matern Child Health J. 2019-11
J Assist Reprod Genet. 2021-5
Fertil Steril. 2016-6
Am J Obstet Gynecol. 2016-1